Denali Therapeutics stock gains as FDA grants priority review for Hunter syndrome drug

Related
Wingstop gains after William Blair points to a long runway o...
8 minutes ago
0
Blackstone, TPG in talks to bid on H&R REIT assets - report
15 minutes ago
0
Why two-time founder and MacArthur Genius Daphne Koller sees...
15 minutes ago
0
Hims & Hers plans Canada expansion to time patent cliff for ...
16 minutes ago
0
Global X Enhanced Bitcoin Covered Call ETF declares $0.175 d...
19 minutes ago
0
Global X Bitcoin Covered Call ETF declares $0.14 dividend
20 minutes ago
0
TechnipFMC, Vaar Energi to partner for development of North ...
21 minutes ago
0
Gen Z are ‘overemployed,’ holding down 5 jobs and earning ov...
28 minutes ago
0
YieldMax BRK.B Option Income Strategy ETF declares $0.5029 d...
30 minutes ago
0
YieldMax Short TSLA Option Income Strategy ETF declares $0.2...
30 minutes ago
0
YieldMax ARKK Innovation Option Income Strategy ETF declares...
32 minutes ago
0
MongoDB rises after Wolfe Research starts coverage with bull...
34 minutes ago
0
Comtech announces COO, CTO, and CFO appointments
46 minutes ago
0
US tariff letter still pending; Go tapped to make announceme...
50 minutes ago
0
Morgan Stanley resumes coverage of Capital One Financial wit...
50 minutes ago
0
PHL ‘stands to benefit’ after US barely budges on region’s t...
51 minutes ago
0
Zambales, Pangasinan set for hydrogen resource exploration
53 minutes ago
0
Organic pesticide developed by D&L unit approved for cocolis...
55 minutes ago
0
Council announces seizure of smuggled rice in Talisay, Cebu
55 minutes ago
0
Prysmian shares surge as cable maker seen winning from U.S. ...
56 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved